Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.00
Bid: 143.00
Ask: 145.00
Change: -4.00 (-2.76%)
Spread: 2.00 (1.399%)
Open: 143.00
High: 145.00
Low: 141.00
Prev. Close: 145.00
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Xaar plc - Commercial partnership with Quantica

5 Jul 2023 09:00

RNS Number : 9635E
Xaar PLC
05 July 2023
 

5 July 2023

 

Xaar plc

 

Commercial partnership with Quantica

 

Xaar plc ("Xaar" or "the Group"), the leading inkjet printing technology group, and Quantica GmbH ("Quantica"), the multi-material 3D printing firm, have signed an exclusive commercial partnership to manufacture Quantica's NovoJet printheads, enabling ultra high viscosity printing for 2D and 3D printing applications. This partnership combines Xaar's expertise in inkjet printhead manufacturing with Quantica's ultra high viscosity printhead technology.

 

Manufacturing will take place at Xaar's high-tech facility in Huntingdon, with both companies expecting the initial NovoJet printheads to be shipping in Quantica's first 3D printers from the end of 2023. 

 

The agreement also gives Xaar commercial access to Quantica's IP in the jetting of highly viscous materials at up to 400cP at jetting temperature. This will complement Xaar's existing printheads and ImagineX technology portfolio which already enable jetting up to 100cP - far beyond other printheads available today.

 

Xaar will now offer the widest capability in printing high-performance materials to its OEM customers, meeting the opportunities for advanced manufacturing applications across electronics, display, industrial coating, adhesive and life-science sectors.

 

Founded in 2018 in Berlin, Quantica has dedicated its research and development efforts to both the novel NovoJet printhead technology and advanced multi-material 3D printers. By partnering with Xaar, a leader in inkjet printhead manufacturing, Quantica will further focus on the development of its 3D printing systems for applications in dental, medical, electronics, R&D, and more.

 

Graham Tweedale, Xaar's Chief Operation Officer, said:

 

"As we continue to accelerate our strategy the combination of our existing ImagineX technologies with the capability offered by Quantica's IP will ensure Xaar offers the widest range of solutions in jetting highly viscous materials."

 

Ramon Borrell, Chief Technology Officer for Quantica, said:

 

"Xaar is widely recognised for the quality of its printheads, and this agreement enables us to focus on delivering the roadmap of innovative NovoJet 3D printers for high performance multi-material parts with full confidence the printheads will deliver for our customers and partners."

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Teneo

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEZLFBXDLEBBF
Date   Source Headline
9th Jun 20112:48 pmRNSDirector/PDMR Shareholding
8th Jun 20117:00 amRNSBoard Changes
17th May 20114:46 pmRNSResult of AGM
5th May 20117:00 amRNSNotice of 2011 AGM and AFR 2010
27th Apr 201111:54 amRNSGrant of Options
21st Apr 20117:00 amRNSInterim Management Statement
7th Apr 20118:00 amRNSDirector/PDMR Shareholding
31st Mar 201110:20 amRNSDirector/PDMR Shareholding
22nd Mar 20117:00 amRNSFinal Results
9th Mar 20114:14 pmRNSHolding(s) in Company
3rd Mar 20118:58 amRNSHolding(s) in Company
20th Jan 20117:00 amRNSYear End Trading Update
21st Dec 201011:12 amRNSGrant of Options
14th Dec 20107:00 amRNSDirectorate Change
18th Nov 20101:58 pmRNSDirector/PDMR Shareholding
15th Nov 201010:51 amRNSHolding(s) in Company
8th Nov 20102:51 pmRNSHolding(s) in Company
8th Nov 20101:48 pmRNSResult of General Meeting
8th Nov 20107:00 amRNSResults of the Placing and Open Offer
21st Oct 20104:33 pmRNSPublication of Prospectus
21st Oct 20104:33 pmRNSPublication of Prospectus
21st Oct 20107:00 amRNSIMS and fundraising
21st Oct 20107:00 amRNSIMS and fundraising
20th Sep 201011:57 amRNSHoldings in Company: Released in Error
20th Sep 201011:26 amRNSHolding(s) in Company
6th Sep 201010:03 amRNSHolding(s) in Company
6th Sep 201010:00 amRNSHolding(s) in Company
2nd Sep 20104:04 pmRNSHolding(s) in Company
24th Aug 201012:44 pmRNSHolding(s) in Company
18th Aug 20107:00 amRNSHalf Yearly Report
6th Aug 20108:55 amRNSHolding(s) in Company
6th Aug 20108:50 amRNSHolding(s) in Company
4th Aug 20103:33 pmRNSNotice of Half Yearly Report
20th Jul 20107:00 amRNSTrading Statement
23rd Jun 20109:18 amRNSHolding(s) in Company
23rd Jun 20109:17 amRNSHolding(s) in Company
22nd Jun 20103:38 pmRNSHolding(s) in Company
14th Jun 20103:06 pmRNSHolding(s) in Company
10th Jun 20102:15 pmRNSHolding(s) in Company
7th Jun 20109:00 amRNSHolding(s) in Company
4th Jun 20101:54 pmRNSHolding(s) in Company
3rd Jun 20104:47 pmRNSHolding(s) in Company
20th May 201011:03 amRNSResult of AGM
20th May 201010:25 amRNSHolding(s) in Company
18th May 20105:44 pmRNSHolding(s) in Company
18th May 20102:13 pmRNSHolding(s) in Company
26th Apr 201011:51 amRNSHolding(s) in Company
22nd Apr 20109:28 amRNSHolding(s) in Company
19th Apr 20107:00 amRNSInterim Management Statement
17th Mar 20107:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.